Identification of OCT6 as a novel organic cation transporter preferentially expressed in hematopoietic cells and leukemias (Q28610047)

2

1 reference

3 February 2017

Yongsheng Xu

3

1 reference

3 February 2017

Carol F. Swiderski

4

1 reference

3 February 2017

Craig T. Jordan

5

1 reference

3 February 2017

Jeffrey A. Moscow

Organic cation transporters in intestine, kidney, liver, and brain

6

1 reference

3 February 2017

1 October 2002

1 reference

3 February 2017

Experimental Hematology

1 reference

3 February 2017

30

1 reference

3 February 2017

10

1 reference

3 February 2017

1162–1169

1 reference

3 February 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900901-3

7 January 2021

Drug excretion mediated by a new prototype of polyspecific transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900901-3

7 January 2021

Role of organic cation transporters in drug absorption and elimination

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900901-3

7 January 2021

Membrane transporters in drug disposition

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900901-3

7 January 2021

Cloning and characterization of two human polyspecific organic cation transporters

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900901-3

7 January 2021

Molecular pharmacology of organic cation transporters in kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900901-3

7 January 2021

cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900901-3

7 January 2021

Cloning and functional characterization of a rat renal organic cation transporter isoform (rOCT1A).

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900901-3

7 January 2021

Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900901-3

7 January 2021

Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900901-3

7 January 2021

Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900901-3

7 January 2021

cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900901-3

7 January 2021

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900901-3

7 January 2021

Reduced folate carrier gene (RFC1) expression and anti-folate resistance in transfected and non-selected cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900901-3

7 January 2021

Rituximab therapy of patients with B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900901-3

7 January 2021

Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900901-3

7 January 2021

Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900901-3

7 January 2021

Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900901-3

7 January 2021